Insider Transactions in Q1 2021 at Viking Therapeutics, Inc. (VKTX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Matthew W Foehr Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
20,000
+30.19%
|
$20,000
$1.5 P/Share
|
|
Jan 19
2021
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,611
-0.3%
|
$33,666
$6.68 P/Share
|
|
Jan 19
2021
|
Michael Morneau VP, Finance and Administration |
SELL
Payment of exercise price or tax liability
|
Direct |
1,685
-1.43%
|
$10,110
$6.68 P/Share
|
|
Jan 19
2021
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
808
-0.89%
|
$4,848
$6.68 P/Share
|
|
Jan 19
2021
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
994
-0.58%
|
$5,964
$6.68 P/Share
|
|
Jan 15
2021
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
686
-0.4%
|
$4,116
$6.48 P/Share
|
|
Jan 04
2021
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,773
-1.59%
|
$13,865
$5.8 P/Share
|
|
Jan 04
2021
|
Marianna Mancini Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,750
+17.03%
|
-
|
|
Jan 04
2021
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,787
-2.99%
|
$13,935
$5.8 P/Share
|
|
Jan 04
2021
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,450
+24.77%
|
-
|
|
Jan 04
2021
|
Michael Morneau VP, Finance and Administration |
SELL
Payment of exercise price or tax liability
|
Direct |
2,739
-2.27%
|
$13,695
$5.8 P/Share
|
|
Jan 04
2021
|
Michael Morneau VP, Finance and Administration |
BUY
Grant, award, or other acquisition
|
Direct |
21,334
+8.33%
|
-
|
|
Jan 04
2021
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,973
-0.89%
|
$84,865
$5.8 P/Share
|
|
Jan 04
2021
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
204,333
+5.05%
|
-
|
|
Jan 03
2021
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,545
-1.81%
|
$157,725
$5.63 P/Share
|